Literature DB >> 32449165

The role of SIRT2 in cancer: A novel therapeutic target.

Guangyuan Chen1, Peng Huang2,3, Cong Hu1.   

Abstract

Sirtuin 2 (SIRT2) belongs to the sirtuins family. It exists in many tissues and organs of the human body and regulates a wide range of biological functions. Studies have found that the abnormal expression of SIRT2 was associated with a variety of malignant tumors. SIRT2 possesses an important role in tumorigenesis, with both tumor-promoting and tumor-suppressing function. However, the mechanisms in which SIRT2 plays the roles in cancer are still controversial. This article reviews the role and molecular mechanism of SIRT2 in tumor evolution, and provides ideas for future research in this field, to guide the targeted therapy and drug development of related malignancies.
© 2020 UICC.

Entities:  

Keywords:  SIRT2; cancer; cell cycle; tumor microenvironment

Mesh:

Substances:

Year:  2020        PMID: 32449165     DOI: 10.1002/ijc.33118

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Sirtuin modulators: past, present, and future perspectives.

Authors:  Francesco Fiorentino; Nicola Mautone; Martina Menna; Francesca D'Acunzo; Antonello Mai; Dante Rotili
Journal:  Future Med Chem       Date:  2022-05-18       Impact factor: 4.767

Review 2.  Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders?

Authors:  Zhang Fan; Li Bin
Journal:  Front Cell Neurosci       Date:  2022-06-22       Impact factor: 6.147

3.  SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters.

Authors:  Dai-Qing Wu; Qiu-Ying Ding; Na-Na Tao; Ming Tan; Yuan Zhang; Fan Li; Yu-Jiao Zhou; Mei-Ling Dong; Sheng-Tao Cheng; Fang Ren; Juan Chen; Ji-Hua Ren
Journal:  Front Microbiol       Date:  2022-05-19       Impact factor: 6.064

Review 4.  Mammalian Sirtuins and Their Relevance in Vascular Calcification.

Authors:  Xinyue Pan; Caixia Pi; Xianchun Ruan; Hanhua Zheng; Demao Zhang; Xiaoheng Liu
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

Review 5.  Role of sirtuins in esophageal cancer: Current status and future prospects.

Authors:  Ryota Otsuka; Koichi Hayano; Hisahiro Matsubara
Journal:  World J Gastrointest Oncol       Date:  2022-04-15

Review 6.  Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies.

Authors:  Sepideh Mirzaei; Kiavash Hushmandi; Amirhossein Zabolian; Hossein Saleki; Seyed Mohammad Reza Torabi; Adnan Ranjbar; SeyedHesam SeyedSaleh; Seyed Omid Sharifzadeh; Haroon Khan; Milad Ashrafizadeh; Ali Zarrabi; Kwang-Seok Ahn
Journal:  Molecules       Date:  2021-04-19       Impact factor: 4.411

7.  Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration.

Authors:  A Vogelmann; M Schiedel; N Wössner; A Merz; D Herp; S Hammelmann; A Colcerasa; G Komaniecki; J Y Hong; M Sum; E Metzger; E Neuwirt; L Zhang; O Einsle; O Groß; R Schüle; H Lin; W Sippl; M Jung
Journal:  RSC Chem Biol       Date:  2022-03-01

8.  Machine-Learning Analysis of Serum Proteomics in Neuropathic Pain after Nerve Injury in Breast Cancer Surgery Points at Chemokine Signaling via SIRT2 Regulation.

Authors:  Jörn Lötsch; Laura Mustonen; Hanna Harno; Eija Kalso
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

9.  Quantitative proteomic analysis of the lysine acetylome reveals diverse SIRT2 substrates.

Authors:  Hui Zhang; Eric B Dammer; Nicholas T Seyfried; David S Yu; Duc M Duong; Diana Danelia
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.996

10.  Celastrol and Resveratrol Modulate SIRT Genes Expression and Exert Anticancer Activity in Colon Cancer Cells and Cancer Stem-like Cells.

Authors:  Helena Moreira; Anna Szyjka; Justyna Grzesik; Katarzyna Pelc; Magdalena Żuk; Anna Kulma; Fathi Emhemmed; Christian D Muller; Kazimierz Gąsiorowski; Ewa Barg
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.